Ginsenoside nanoparticle: a new green drug delivery system

Area of Science:

• Green Chemistry
• Nanotechnology
• Pharmaceutical Sciences

Background:

• Chemosynthetic nano-drug carriers often require high doses, posing toxicity risks.
• Green chemistry seeks eco-friendly nanoparticles to reduce harmful ingredients and enable lower-dose treatments.
• Non-toxic pharmaceutical formulations minimize adverse effects from drug residues in the body and environment.

Purpose of the Study:

• To investigate the potential of ginsenoside Rb1, a component of Panax ginseng, in forming self-assembled nanoparticles with anticancer drugs.
• To evaluate the efficacy and characteristics of these ginsenoside-based nanoparticles for cancer therapy.
• To explore a green and scalable method for producing novel nanocarriers.

Main Methods:

• Self-assembly of ginsenoside Rb1 with anticancer drugs (betulinic acid, dihydroartemisinin, hydroxycamptothecine).
• Characterization of nanoparticle size (∼100 nm), drug loading capacity, and tumor selectivity.
• In vitro and in vivo evaluation of anticancer effects and side effects in a mouse tumor xenograft model.

Main Results:

• Ginsenoside Rb1 formed stable nanoparticles with high drug loading capacities (up to ∼35 wt%).
• The nanoparticles demonstrated superior in vitro and in vivo anticancer activity compared to free drugs.
• Enhanced tumor selectivity and prolonged blood circulation half-time were observed.
• The nanocarrier system showed significant tumor inhibition with fewer side effects in mice.

Conclusions:

• Ginsenoside Rb1 can serve as an effective, self-assembling nanocarrier for anticancer drugs.
• These green nanoparticles offer a promising platform for enhanced cancer therapy with reduced toxicity.
• The simple preparation and scalability support their potential for broad application in drug delivery.